- Published at
- by seekingalpha.com
mixed
mixed
Conestoga Mid Cap Composite Q2 2025 Commentary
Conestoga trailed in Q2 as AI-fueled stocks surged, but stayed focused on quality mid caps. See how they’re positioning for long-term growth over hype.
News for IDEXX Laboratories, Inc. (IX1.DE)
- Published at
- by seekingalpha.com
mixedmixedBaron Health Care Fund Q2 2025 Shareholder Letter
Baron Health Care Fund declined for the quarter but outperformed its benchmark, the Russell 3000 Health Care Index. Read more here.UNHD.BASYK.MXSYK.DESYKS1YK34.SAPENMRKD.BAMRK.SNMRK.PAMRK.MXMRKLLY.MXLLY.DELLY.BALLYLILY34.SAIX1.DEISRG.MXISRGINSMIDXX.MXIDXXI1DX34.SAEWL.DEEW.MXEWE1WL34.SACOO.MXCOOC1OO34.SABSX.MXBSX-PABSXBRM.DEBMYB34.SABMY.MXBMY.BABMYB1SX34.SAARGX.BRARGXARGNFA1RG34.SA6MK.DE0R2S.L0R29.L0Q1G.L0JEV.L0JAV.L0J8P.L0I3I.L0HOY.LWATC34.SAWAT.MXWATUNHH34.SAUNH.MXUNH.DEUNH.BAUNHTMO.MXTMOMCK.MXMCKMASI.MXMASIM1CK34.SAHQYEXASDHR.MXDHRDHER34.SADAP.DE0R2B.L0R0H.L0LTI.L0JZU.L0JZ2.LSUP.LRDNT- Published at
- by gurufocus.com
positivepositiveIDXX: Analyst Leerink Partners Raises Price Target to $600 | IDXX Stock News
On July 17, 2025, Leerink Partners analyst Daniel Clark reaffirmed his "Outperform" rating on IDEXX Laboratories (IDXX) while raising the price target from $580- Published at
- by gurufocus.com
positivepositiveIdexx Laboratories (IDXX) Sees Raised Price Target from Leerink Analyst | IDXX Stock News
Leerink analyst, Daniel Clark, has increased the price target for Idexx Laboratories (IDXX) from $580 to $600 while maintaining an Outperform rating for the sto- Published at
- by seekingalpha.com
positivepositiveIDEXX Laboratories, Inc.: A Business With Very Strong Fundamentals (NASDAQ:IDXX)
IDEXX Laboratories benefits from strong pet care trends, new platform adoption, and a high-margin recurring model that drives growth. See why IDXX stock is a buy.- Published at
- by finance.yahoo.com
neutralneutralHere's What to Expect From IDEXX Laboratories' Next Earnings Report
IDEXX Laboratories is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit earnings growth.- Published at
- by gurufocus.com
positivepositiveIDEXX Laboratories (IDXX) Announces Election of New Independent Director
IDEXX Laboratories, Inc. (IDXX) has announced the election of Joseph L. (Jay) Hooley as an independent Class III Director, effective July 10, 2025. Mr. Hooley- Published at
- by gurufocus.com
mixedmixedIDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Joseph L. (Jay) Hooley to the Company's- Published at
- by gurufocus.com
positivepositiveIDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors | IDXX Stock News
IDEXX Laboratories (IDXX) has appointed Joseph L. (Jay) Hooley to its Board of Directors, effective July 10, 2025. Jay Hooley brings extensive strategic- Published at
- by gurufocus.com
neutralneutralIDEXX Laboratories (IDXX) Price Target Raised by Stifel | IDXX Stock News
On July 2, 2025, Stifel maintained its "Hold" rating on IDEXX Laboratories, Inc. (IDXX), a leading company known for developing and offering diagnostic products- Published at
- by gurufocus.com
positivepositiveIDXX Stock Surges with Strong Q1 Results and Growth Projections
Quick Highlights: IDEXX Laboratories (IDXX) reports a robust Q2 2025 performance with significant gains. Wall Street forecasts suggest a stable outlook w- Published at
- by benzinga.com
mixedmixedTwo US Lawmakers On The Armed Services Committee Quietly Snapped Up L3Harris Shares Leading Up To Iran Tensions: 'This Shouldn't Be Legal' - IDEXX Laboratories (NASDAQ:IDXX), L3Harris Technologies (NY
Two U.S. lawmakers are being called out after disclosing their stock purchases involving defense contractor L3Harris Technologies Inc. (NYSE: LHX), in the lead up to conflict with Iran, while serving on the Congressional Armed Services Committee.- Published at
- by seekingalpha.com
mixedmixedMacquarie Large Cap Growth Fund Q1 2025 Commentary
For 1Q25, Macquarie Large Cap Growth Fund Institutional Class shares posted negative absolute returns but outperformed the Fund’s benchmark, the Russell 1000® Growth Index.WCN.TOWCNMQGPE.AXMQGPD.AXMQGPC.AXMQG.AXMQBKYMCQEFVISA34.SAVD.BAVCL.SNVC.BAV.SWV.SNV.MXV.BAVMBLPD.AXKOD.BAKOCL.SNKOC.BAICE.MXICEIC2.DE3V64.DE0JC3.LUNHD.BANVDC34.SANVDA.MXNVDA.BANVDANVD.DEMSFT.SNMSFT.MXMSFTMSF.DEMSF.BRIX1.DEIDXX.MXIDXXI1DX34.SAGOOGL.SNGOOGL.MXGOOGL.BAGOOGLGOOGCL.SNGOOG.SNGOOG.MXGOOGGOGLD.BAERT.DEEAIN34.SAEA.MXEAAVGOPAVGOD.BAAVGO34.SAAVGO.MXAVGO.BAAVGOAPC.DEAMZNCL.SNAMZN.SNAMZN.MXAMZNAMZ.DEABEC.DEABEA.DEAAPLD.BAAAPLCL.SNAAPLC.BAAAPL.SNAAPL.NEAAPL.MXAAPL.BAAAPL1YD.DE0YXG.L0J8P.L0IFX.L- Published at
- by insidermonkey.com
neutralneutralJim Cramer on IDEXX Laboratories, Inc. (IDXX): “I Just Can’t Get My Arms Around It”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at where IDEXX Laboratories, Inc.- Published at
- by gurufocus.com
positivepositiveIDEXX Laboratories (IDXX) Target Price Raised by Stifel to $510 | IDXX Stock News
On May 19, 2025, Stifel analyst Jonathan Block decided to maintain a "Hold" rating for IDEXX Laboratories (IDXX), a prominent player in the diagnostic and IT so- Published at
- by seekingalpha.com
positivepositiveIDEXX Laboratories: Growth Remains Despite Weak Clinical Visits (NASDAQ:IDXX)
IDEXX Laboratories, Inc. reports strong Q1 FY25 growth with 4.7% organic revenue. Click for my updated look at IDXX stock post earnings.- Published at
- by gurufocus.com
neutralneutralIDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day | IDXX Stock News
IDEXX Laboratories (IDXX) executives to participate in Stifel Jaws & Paws Conference on May 28, 2025. Company announces 2025 Investor Day scheduled for- Published at
- by gurufocus.com
positivepositiveIDEXX Laboratories (IDXX) Announces Key Amendments to Corporate Structure
IDEXX Laboratories, Inc. (IDXX) has made significant changes to its corporate structure following the 2025 Annual Meeting of Stockholders held on May 7, 2025.- Published at
- by gurufocus.com
positivepositiveWallace Weitz's Strategic Moves: A Closer Look at Microsoft Corp's Impactful Increase
Exploring the Investment Strategies of a Renowned Value Investor Wallace Weitz (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2- Published at
- by finance.yahoo.com
positivepositiveHere’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX)
Baron Funds, an investment management firm, released its “Focused Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Q1 was a difficult start to the year. The fund declined 7.95% (Institutional Shares) in the quarter, compared to the Russell 2500 Growth Index’s (the Benchmark) 10.80% return. Please spare […]